AbbVie forecasts 2026 adjusted EPS of $13.87-$14.07 as it expects ~$67.6B revenue and Q3 EPS of $3.84-$3.88

EarningsNeutral

AI Analysis

Summary

AbbVie issued 2026 financial guidance forecasting adjusted EPS of $13.87-$14.07 and revenue of approximately $67.6B, along with Q3 EPS guidance of $3.84-$3.88.

Financial Highlights

Revenue

$67.6B

EPS

Q3 $3.84-$3.88, 2026 adjusted $13.87-$14.07

Guidance

2026 adjusted EPS guidance $13.87-$14.07; expected 2026 revenue ~$67.6B

Importance:4/10

Sentiment:

0.00

earnings guidancefinancial forecast2026 outlook

Related Companies

$ABBV

Read the original article

Published by Seeking Alpha Healthcare on July 31, 2026 8:25 PM

Read Original